Biofil Chemicals & Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

30.04

22.38

35.75

29.69

23.13

Operating profit

1.17

1.33

1.60

1.82

1.02

Interest

0.04

0.04

0.07

0.12

0.16

Gross profit

1.22

1.44

2.34

1.87

0.96

EPS (Rs)

0.34

0.43

0.77

0.74

0.30

Other income

0.10

0.15

0.80

0.17

0.10

Stock adjustment

-0.20

3.59

-2.77

-0.34

0.17

Raw material

3.92

2.27

6.85

4.06

0.77

Power and fuel

-

-

-

-

-

Employee expenses

0.62

0.79

0.75

0.86

0.89

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

24.53

14.41

29.32

23.29

20.27

Provisions made

-

-

-

-

-

Depreciation

0.43

0.43

0.41

0.41

0.37

Taxation

0.23

0.32

0.68

0.26

0.12

Net profit / loss

0.56

0.70

1.25

1.21

0.48

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.27

16.27

16.27

16.27

16.27

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

3.89

5.95

4.47

6.14

4.42

GPM (%)

4.06

6.40

6.39

6.27

4.15

NPM (%)

1.86

3.10

3.41

4.04

2.08